Research from Redeye, Redeye AB

Redeye

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen). 

Expertise in Denmark, Finland, Norway and Sweden.

Research from Redeye

Redeye AB

Specialists in innovative and fast-growing Nordic companies within Life Science and Technology.

Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology. We are the leading provider of Corporate Broking and Corporate Finance in these sectors.

Our clients are innovative growth companies in the Nordics and we use a unique Rating model based on a value based investment philosophy. Redeye was founded 1999 in Stockholm and is regulated by the Swedish Financial Authority (Finansinspektionen).

Equity Bottom-Up

<ul><li>Redeye is encouraged by FluoGuide receiving FDA Fast Track Designation for FG001 in High-Grade Glioma.</li><li>This gives positive regulatory momentum ahead of the U.S. Phase 2 registration trial.</li><li>We expect the share to trade up at least 15% today.</li></ul>

Redeye is encouraged by FluoGuide receiving FDA Fast Track Designation for FG001 in High-Grade Glioma.This gives positive regulatory momentum ahead of the U.S. Phase 2 registration trial.We expect the share to trade up at least 15% today.

FluoGuide: FG001 receives Fast Track designation

Fluoguide

FluoGuide: FG001 receives Fast Track designation